NCT06038838View on ClinicalTrials.gov

Feasibility Study of the Tioga TMVR System

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

January 1, 2025

Study Completion Date

December 1, 2026

Conditions
Mitral Regurgitation
Interventions
DEVICE

Tioga TMVR System

A bioprosthetic mitral valve, as part of the Tioga TMVR System, is implanted percutaneously in a patient with MR via transfemoral-transseptal access.

All Listed Sponsors
lead

Tioga Cardiovascular, Inc.

INDUSTRY